Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernewsroom.regeneron.com
Regeneron Pharmaceuticals Inc. News Releases
Get the latest updates from Regeneron Pharmaceuticals Inc. News Releases directly as they happen.
Follow now 141 followers
Latest posts
Last updated 3 days ago
Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis
3 days ago
Cemdisiran monotherapy, dosed subcutaneously every three months, met the primary and key...
EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension
9 days ago
TARRYTOWN, N.Y. , Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
Regeneron Announces Investor Conference Presentations
21 days ago
TARRYTOWN, N.Y. , Aug. 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
Regeneron Reports Second Quarter 2025 Financial and Operating Results
28 days ago
Second quarter 2025 revenues increased 4% to $3.68 billion versus second quarter...
Regeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation
about 1 month ago
TARRYTOWN, N.Y. , July 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals...
Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma
about 2 months ago
TARRYTOWN, N.Y. , July 02, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
2 months ago
TARRYTOWN, N.Y. , June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
2 months ago
Initiative aims to expand and encourage philanthropy to help patients with retinal...
Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)
2 months ago
Approval based on pivotal results showing improvements in sustained disease remission and...
Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial
2 months ago
New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary...
Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color
3 months ago
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color...
Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic In-Licensing of Novel Dual GLP-1/GIP Receptor Agonist
3 months ago
New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP...